INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Sagent Pharmaceuticals, Inc. ...
18 Luglio 2016 - 6:55PM
Business Wire
The following statement is being issued by Levi & Korsinsky,
LLP:
To: All Persons or Entities who purchased Sagent
Pharmaceuticals, Inc. (“Sagent”) (NASDAQ: SGNT) stock prior to July 11, 2016.
You are hereby notified that Levi & Korsinsky, LLP
has commenced an investigation into the fairness of the
sale of Sagent to Nichi-Iko Pharmaceutical Co., Ltd. for $21.75
per share. To learn more about the action and your rights, go
to:
http://zlk.9nl.com/sagent-pharmaceuticals-sgnt
or contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877)
363-5972. There is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, Connecticut, California, and Washington D.C. The
firm’s attorneys have extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors
throughout the nation in securities lawsuits and have recovered
hundreds of millions of dollars for aggrieved shareholders. For
more information, please feel free to contact any of the attorneys
listed below. Attorney advertising. Prior results do not guarantee
similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160718006109/en/
Levi & Korsinsky, LLPJoseph E. Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
212-363-7171www.zlk.com
Grafico Azioni Sagent (NASDAQ:SGNT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Sagent (NASDAQ:SGNT)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Sagent Pharmaceuticals, Inc. (NASDAQ): 0 articoli recenti
Più Sagent Pharmaceuticals, Inc. (MM) Articoli Notizie